YM201636 decreased IL-10 production induced by CpG but increased that induced by LPS in mouse peritoneal macrophages. by Kaoru Hazeki (340967)

(a) 2D CAD model of tool (b) fabricated tool (c) tool pin geometry. by Shaheer Ahmed Khan (17797647)

This figure indicates the location of The Netherlands within Europe; a map of The Netherlands; and the location of the colonies used in this study. by Estefania Velilla (22566709)

DCP-LA treatment of SN56 cells diverts APP into early endosome compartments. by Joshua H. K. Tam (836784)

L1 animals lacking <i>adr-2</i> have decreased expression of genes regulated by insulin signaling. by Ananya Mahapatra (17041557)

The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

“…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”

S1 File - by Fatma Karapinar-Çarkıt (3956189)

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”

PPAR-γ inhibition increases IL-8 secretion and decreases β-defensin 2 expression in primary NHBE cells. by Fabienne Gally (260470)

Cost-utility analyses. by Fatma Karapinar-Çarkıt (3956189)

Flowchart of inclusion of patients. by Fatma Karapinar-Çarkıt (3956189)

Data_Sheet_1_A randomized double-blinded study assessing the effect of different doses of transnasal dexmedetomidine on the median effective concentration of ropivacaine for a caud... by Fu Wang (10556)

“…</p>Conclusion<p>IN-DEX decreased the EC50 of ropivacaine for the caudal block, and there was a specific dose-dependent effect for IN-DEX. …”

The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice. by Pia Steensland (362091)

“…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). However, ezlopitant treatment failed to induce a significant decrease in ethanol consumption compared to vehicle (<b>B</b>). …”

Cost-effectiveness analyses for drug-related rehospitalisations. by Fatma Karapinar-Çarkıt (3956189)

Cost-effectiveness analyses for unplanned rehospitalisations. by Fatma Karapinar-Çarkıt (3956189)

Patient characteristics for usual care and the COACH program. by Fatma Karapinar-Çarkıt (3956189)

Results of adjusted cost-effectiveness and cost-utility analyses. by Fatma Karapinar-Çarkıt (3956189)

Costs used in the economic evaluation, corrected for the year 2011. by Fatma Karapinar-Çarkıt (3956189)

DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

“…</p>Results<p>ULT resulted in a mean (standard deviation) decrease in SU level (464.22 ± 110.21 μmol/L at baseline, 360.93 ± 91.66 μmol/L at the final visit, p <0.001) accompanied by a decrease in median (interquartile range) VFA [97.30 (81.15–118.55) at baseline, 90.90 (75.85–110.05) at the final visit, p < 0.001]. …”

The Dose–Response Decrease in Heart Rate Variability: Any Association with the Metabolites of Polycyclic Aromatic Hydrocarbons in Coke Oven Workers? by Xiaohai Li (136211)

“…After adjustment for potential confounders, elevation per interquartile range (IQR) (1.81 µg/mmol creatinine) of urinary 2-hydroxynaphthalene was associated with a 5.46% (95% CI, 2.50–8.32) decrease in standard deviation of NN intervals (SDNN). …”